Related Experiment Video
Updated: Jul 1, 2025

Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma
Haruna Fujimori1, Mao Shima-Nakamura1, Shin-Ichiro Kanno2
1Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
Abstract:
Cholangiocarcinoma (CCA) is one of the most difficult malignancies to treat as the therapeutic options are limited. Although several driver genes have been identified, most remain unknown. In this study, we identified a failed axon connection homolog (FAXC), whose function is unknown in mammals, by analyzing serially passaged CCA xenograft models. Knockdown of FAXC reduced subcutaneous tumorigenicity in mice. FAXC was bound to annexin A2 (ANXA2) and c-SRC, which are tumor-promoting genes. The FAXC/ANXA2/c-SRC complex forms in the mitochondria. FAXC enhances SRC-dependent ANXA2 phosphorylation at tyrosine-24, and the C-terminal amino acid residues (351-375) of FAXC are required for ANXA2 phosphorylation. Transcriptome data from a xenografted CCA cell line revealed that FAXC correlated with epithelial-mesenchymal transition, hypoxia, and KRAS signaling genes. Collectively, these findings advance our understanding of CCA tumorigenesis and provide candidate therapeutic targets.
Insights
Researchers identified a novel gene, failed axon connection homolog (FAXC), crucial for cholangiocarcinoma (CCA) tumor growth. Targeting FAXC may offer new therapeutic strategies for this difficult-to-treat cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cholangiocarcinoma (CCA) presents limited therapeutic options due to poorly understood driver genes.
- Identifying novel targets is critical for advancing CCA treatment strategies.
Purpose of the Study:
- To identify novel genes involved in CCA tumorigenesis.
- To elucidate the functional role of failed axon connection homolog (FAXC) in CCA.
Main Methods:
- Analysis of serially passaged CCA xenograft models.
- Gene knockdown experiments to assess tumorigenicity.
- Protein complex analysis (FAXC/ANXA2/c-SRC).
- Transcriptome analysis of CCA cell lines.
Main Results:
- FAXC knockdown significantly reduced CCA subcutaneous tumorigenicity in mice.
- FAXC forms a complex with tumor-promoting genes annexin A2 (ANXA2) and c-SRC in mitochondria.
- FAXC promotes SRC-dependent ANXA2 phosphorylation at tyrosine-24, requiring specific C-terminal residues.
- FAXC expression correlates with epithelial-mesenchymal transition, hypoxia, and KRAS signaling pathways in CCA.
Conclusions:
- FAXC plays a significant role in CCA tumorigenesis.
- The FAXC/ANXA2/c-SRC complex represents a potential therapeutic target.
- Understanding FAXC's function provides insights into CCA progression and identifies new avenues for treatment.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Abnormal Proliferation

